Table 1.
Targeted receptor | Mechanism | Associated disease | References |
---|---|---|---|
Endothelial receptor type A (ETAR) | Activation | Pulmonary arterial hypertension (PAH) | [1] |
Angiotensin II receptor (AT1R), ETAR | Activation | Systemic sclerosis | [2] |
AT1R | Activating | Preeclampsia | [3–5] |
α 1-adrenergic receptors (α 1-ARs) | Activating | Refractory hypertension | [3, 6, 7] |
β 1-adrenergic receptor | Activation | Dilated cardiomyopathy (DCM), Chagas' disease | [8, 9] |
N-methyl-D-aspartate receptor (NMDAR) | Activation | SLE | [10] |
Glutamate receptor | Activation | SLE | [11] |
Insulin receptor | Inhibition | Autoimmune hypoglycemia | [12] |
Muscarinic type 3 receptor | Internalization | Sjögren's syndrome | [13] |
NMDAR | Internalization | Anti-NMDA receptor encephalitis | [14] |